Soft tissue and skeletal involvement in FIP1L1-PDGFR-alpha positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission.

Haematologica

Volumn 89, Issue 8, 2004, Pages

  Malagola, Michele ^a   Martinelli, Giovanni ^a   Rondoni, Michela ^a   Ottaviani, Emanuela ^a   Piccaluga, Pier Paolo ^a   Ricci, Paolo ^a   Visani, Giuseppe ^a   Baccarani, Michele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; FIP1L1 PROTEIN, HUMAN; IMATINIB; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PYRIMIDINE DERIVATIVE;

ARTICLE; BLOOD; BONE MARROW; CASE REPORT; CHRONIC DISEASE; HUMAN; HYPEREOSINOPHILIC SYNDROME; MALE; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BONE MARROW; CHRONIC DISEASE; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MIDDLE AGED; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TREATMENT OUTCOME;

EID: 20344369897     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: None     Document Type: Article

References (0)